Colon cancer is a momentous reason for illness and death in people. The conclusive diagnosis of colon cancer is made through histological examination. Convolutional neural networks are being used to analyze colon cancer via digital image processing with the introduction of whole-slide imaging. Accurate categorization of colon cancers is necessary for capable analysis. Our objective is to promote a system for detecting and classifying colon adenocarcinomas by applying a deep convolutional neural network (DCNN) model with some preprocessing techniques on digital histopathology images. It is a leading cause of cancer-related death, despite the fact that both traditional and modern methods are capable of comparing images that may encompass cancer regions of various sorts after looking at a significant number of colon cancer images. The fundamental problem for colon histopathologists is differentiating benign from malignant illnesses to having some complicated factors. A cancer diagnosis can be automated through artificial intelligence (AI), enabling us to appraise more patients in less time and at a decreased cost. Modern deep learning (MDL) and digital image processing (DIP) approaches are used to accomplish this. The results indicate that the proposed structure can accurately analyze cancer tissues to a maximum of 99.80%. By implementing this approach, medical practitioners will establish an automated and reliable system for detecting various forms of colon cancer. Moreover, CAD systems will be built in the near future to extract numerous aspects from colonoscopic images for use as a preprocessing module for colon cancer diagnosis.

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection results in the development of a highly contagious respiratory ailment known as new coronavirus disease (COVID-19). Despite the fact that the prevalence of COVID-19 continues to rise, it is still unclear how people become infected with SARS-CoV-2 and how patients with COVID-19 become so unwell. Detecting biomarkers for COVID-19 using peripheral blood mononuclear cells (PBMCs) may aid in drug development and treatment. This research aimed to find blood cell transcripts that represent levels of gene expression associated with COVID-19 progression. Through the development of a bioinformatics pipeline, two RNA-Seq transcriptomic datasets and one microarray dataset were studied and discovered 102 significant differentially expressed genes (DEGs) that were shared by three datasets derived from PBMCs. To identify the roles of these DEGs, we discovered disease-gene association networks and signaling pathways, as well as we performed gene ontology (GO) studies and identified hub protein. Identified significant gene ontology and molecular pathways improved our understanding of the pathophysiology of COVID-19, and our identified blood-based hub proteins TPX2, DLGAP5, NCAPG, CCNB1, KIF11, HJURP, AURKB, BUB1B, TTK, and TOP2A could be used for the development of therapeutic intervention. In COVID-19 subjects, we discovered effective putative connections between pathological processes in the transcripts blood cells, suggesting that blood cells could be used to diagnose and monitor the disease’s initiation and progression as well as developing drug therapeutics.

With high inflammatory states from both COVID-19 and HIV conditions further result in complications. The ongoing confrontation between these two viral infections can be avoided by adopting suitable management measures. The aim of this study was to figure out the pharmacological mechanism behind apigenin's role in the synergetic effects of COVID-19 to the progression of HIV patients. We employed computer-aided methods to uncover similar biological targets and signaling pathways associated with COVID-19 and HIV, along with bioinformatics and network pharmacology techniques to assess the synergetic effects of apigenin on COVID-19 to the progression of HIV, as well as pharmacokinetics analysis to examine apigenin's safety in the human body. Stress-responsive, membrane receptor, and induction pathways were mostly involved in gene ontology (GO) pathways, whereas apoptosis and inflammatory pathways were significantly associated in the Kyoto encyclopedia of genes and genomes (KEGG). The top 20 hub genes were detected utilizing the shortest path ranked by degree method and protein-protein interaction (PPI), as well as molecular docking and molecular dynamics simulation were performed, revealing apigenin's strong interaction with hub proteins (MAPK3, RELA, MAPK1, EP300, and AKT1). Moreover, the pharmacokinetic features of apigenin revealed that it is an effective therapeutic agent with minimal adverse effects, for instance, hepatoxicity. Synergetic effects of COVID-19 on the progression of HIV may still be a danger to global public health. Consequently, advanced solutions are required to give valid information regarding apigenin as a suitable therapeutic agent for the management of COVID-19 and HIV synergetic effects. However, the findings have yet to be confirmed in patients, suggesting more in vitro and in vivo studies.

Influenza A viruses (IAVs) represent a persistent threat to global public health because of their capacity to cross species barriers and rapidly adapt to new hosts. Posttranslational modifications (PTMs) are known to regulate viral protein function, yet the evolutionary dynamics of PTM sites across influenza strains remain largely uncharacterized. In this study, we employed MusiteDeep to computationally predict potential PTM sites across influenza A virus proteins from H1N1, H5N1, and H7N9. We modeled predicted PTM states as discrete evolutionary traits using Bayesian phylogenetic methods to examine patterns of evolutionary rate variation at these computationally identified sites. Our analysis identified 34 positions at predicted PTM sites showing either significantly elevated (11 sites) or reduced (23 sites) evolutionary rates relative to other PTM-associated positions within each protein. Fast-evolving sites were enriched in polymerase proteins and surface glycoproteins, where slowly evolving sites were more broadly distributed, with notable concentrations in PB1 polymerase and NS1 protein. A subset of these sites showed potential host-associated rate differences, suggesting that selective pressures on PTM sites may differ across host lineages.